Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients

Yusuke Adachi1, Arihiro Kiyosue2, Jiro Ando1

  • 1Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Scientific Reports
|January 9, 2021
PubMed

Insights

Unprotected left main coronary artery intervention may improve left ventricular reverse remodelling in patients with coronary artery disease and reduced ejection fraction. Prior PCI and restenosis were associated with poorer outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Imaging

Background:

  • Percutaneous coronary intervention (PCI) is an alternative to surgical revascularization for coronary artery disease (CAD).
  • Predictors of left ventricular reverse remodelling (LVRR) after PCI in patients with reduced left ventricular ejection fraction (LVEF) are not well-defined.

Purpose of the Study:

  • To identify determinants of LVRR following PCI in patients with CAD and reduced LVEF.

Main Methods:

  • Analysis of 286 patients with LVEF < 50% who underwent PCI.
  • LVRR defined as LV end-systolic volume reduction ≥ 15% and LVEF improvement ≥ 10% at 6-month follow-up.
  • Multivariate logistic regression used to identify predictors of LVRR.

Main Results:

  • Unprotected left main coronary artery (LMCA) intervention was significantly associated with LVRR (OR 4.70).
  • Prior PCI (OR 0.35), in-stent restenosis (OR 0.32), and de-novo stenosis (OR 0.36) were negatively associated with LVRR.

Conclusions:

  • Unprotected LMCA intervention may offer prognostic benefits for LVRR in CAD patients with LV systolic dysfunction.
  • Regular angiographic follow-up is crucial for patients with CAD and LV systolic dysfunction.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
244
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
153
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
177
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
157
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
126